African Journal of
Biotechnology

  • Abbreviation: Afr. J. Biotechnol.
  • Language: English
  • ISSN: 1684-5315
  • DOI: 10.5897/AJB
  • Start Year: 2002
  • Published Articles: 12490

Short Communication

In vitro antiglycation activity of Eremurus persicus (Jaub. Et Sp.) Boiss

Jinous Asgarpanah1*, Gholamreza Amin2 and Malihe Parviz3
  1Department of Pharmacognosy, Pharmaceutical Sciences Branch, Islamic Azad University (IAU), Tehran, Iran. 2Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. 3Young Researchers Club (YRC), Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, Iran.
Email: [email protected]

  •  Accepted: 07 July 2011
  •  Published: 19 September 2011

Abstract

 

Diabetes mellitus is a common endocrine disorder characterized by hyperglycemia and long-term complications affecting the eyes, nerves, blood vessels, skin and kidneys. Increased glycation of proteins and accumulation of advanced glycation endproducts (AGEPs) have been implicated in the pathogenesis of diabeticcomplications. Glycation and AGEP formation are also accompanied by the formation of free radicals via autoxidation of glucose and glycated proteins. Since this plant Eremurus persicus is used as an antidiabetic agent in Iranian traditional medicine, we were prompted to evaluate the antiglycation activity of this species. Here, we reported the isolation of a known compound, 5,6,7-trimethoxy-coumarinfor the first time for the antiglycation properties of this plant.

 

Key words: Antiglycation, Eremurus persicus, 5,6,7-trimethoxy-coumarin.